Molecular-structure (Bpp Sr Z 1)
Bupropion Hydrochloride
Product Images NDC 10370-204
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 10370-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bottle-labeling-150mg (Bpp Sr Z 2)
This is a medication label for a drug called Bupropon Hydrochloride Extended-Release tablets containing 150 mg. It is recommended to store the tablets at 20° to 26°C. The usual dosage instructions are not provided, and it is advised to refer to the prescribing information for dosage guidance. The drug should be kept out of reach of children and dispensed in a light-resistant container. The manufacturer is Par Pharmaceutical. The drug is also known as Wellbutrin® and Wellbutrin SR®, registered trademarks of GlaxoSmithKline.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
